Peer Review reports
From: A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
Original Submission | ||
---|---|---|
2 Aug 2016 | Submitted | Original manuscript |
3 Oct 2016 | Reviewed | Reviewer Report - John McAuliffe |
19 Oct 2016 | Reviewed | Reviewer Report - Motoyoshi Tanaka |
17 Nov 2016 | Author responded | Author comments - Berta Laquente |
Resubmission - Version 2 | ||
17 Nov 2016 | Submitted | Manuscript version 2 |
15 Dec 2016 | Author responded | Author comments - Berta Laquente |
Resubmission - Version 3 | ||
15 Dec 2016 | Submitted | Manuscript version 3 |
20 Jan 2017 | Author responded | Author comments - Berta Laquente |
Resubmission - Version 4 | ||
20 Jan 2017 | Submitted | Manuscript version 4 |
6 Feb 2017 | Author responded | Author comments - Berta Laquente |
Resubmission - Version 5 | ||
6 Feb 2017 | Submitted | Manuscript version 5 |
Publishing | ||
9 Feb 2017 | Editorially accepted | |
15 Feb 2017 | Article published | 10.1186/s12885-017-3131-x |
You can find further information about peer review here.